IDH1 and central nervous system cancer: Due to the importance of the IDH gene for glioma formation and prognosis, the 2021 WHO Classification of Tumors of the Central Nervous System classifies WHO grade 4 gliomas into WHO grade 4 IDH-mutant astrocytoma and IDH-wildtype GBM4.